Annual / Quarterly Financial Statement • Feb 16, 2018
Annual / Quarterly Financial Statement
Open in ViewerOpens in native device viewer
PALMBOOMEN CULTUUR MAATSCHAPPIJ MOPOLI Naamloze Vennootschap (PALMERAIES DE MOPOLI) Société Anonyme
Registred office : 13, J.W. Frisolaan-2517 JS LA HAYE Headquarter : 2, Place du Champ de Mars-1050 BRUXELLES
105th FINANCIAL YEAR 2017/2018
Unaudited
With reference to section 5.25c paragraph 2c of the Financial Markets Supervision Act, the Board of Directors states that, to the best of its knowledge:
Daniel Haas Philippe de Traux Director Director
AFICO represented by Luc Boedt Hubert Fabri Director Director
Mopoli is a holding company focused on tropical agro-industry. The company is listed on the Belgium stock exchange.
The general meeting of shareholders has authorized the company to buy back its own shares. This program has been active for several years, however the availability of shares is limited. The strategy of the company remains to buy back their own shares in case any shares are offered to the market.
Mopoli has two outstanding loans granted to Socfinaf and Afico.
The financial half-year ended at 31 December 2017 with a profit of 175 843 Euros versus a profit of 12 194 024 Euros as at 31 December 2016.
The 2016 half-year result included the non-recurring gain of 11 622 453 euros on disposal of Socfin shares.
At 31 December 2017, the total of the Mopoli IFRS Balance Sheet is 54.2 million Euros against 53.6 million Euros as at 31 December 2016. The Mopoli's asset is composed mainly of a non-current receivables for 10.0 million Euros, short-term receivables for 20.3 million Euros and a cash deposit of 23.9 million Euros. At 31 December 2017, the equity is 54.1 million Euros against 53.5 million Euros a year ago.
The Extraordinary General Meeting hold on the 10th June 2008 authorized the company to buy back its own shares pursuant article 2:98 of the Dutch Civil code. A fourth renewal was approved by the General Meeting on 19th December 2017 for 18 months from 10th June 2017. At the year end, the company holds 5.753 ordinary and 218 founders shares.
Earnings will depend on the remuneration of loans and cash deposits.
The management do not foresee any specific or noted any new uncertainties that the company should have to face for the remaining six months of the financial year.
The Directors
| (in thousands of Euro) | Notes | 31 December 2017 | 31 December 2016 | |
|---|---|---|---|---|
| NON-CURRENT ASSETS | 10 000 | 10 000 | ||
| I. | Available for sale investments | 2 | 0 | 0 |
| II. | Other receivables | 3 | 10 000 | 10 000 |
| CURRENT ASSETS | 44 247 | 43 554 | ||
| III. | Other receivables | 3 | 20 348 | 20 123 |
| IV. | Cash and short-term deposits | 4 | 23 899 | 23 427 |
| V. | Other current assets | 0 | 4 | |
| TOTAL ASSETS | 54 247 | 53 554 | ||
| (in thousands of Euro) | Notes | 31 December 2017 | 31 December 2016 |
|---|---|---|---|
| EQUITY | 54 091 | 53 507 | |
| I. Share capital |
5 | 2 314 | 2 314 |
| II. Revaluation reserves |
5 | 0 | 0 |
| III. Statutory reserves |
5 | 231 | 231 |
| IV. Available reserves |
5 | 523 | 523 |
| V. Result for the year |
5 | 175 | 12 194 |
| VI. Retained earnings |
5 | 54 170 | 41 560 |
| VII. Treasury Shares |
5 | -3 322 | -3 315 |
| NON-CURRENT LIABILITIES | 0 | 0 | |
| VIII. Deferred tax | 0 | 0 | |
| IX. Other long-term payables |
0 | 0 | |
| CURRENT LIABILITIES | 156 | 47 | |
| X. Trade and other payables |
156 | 46 | |
| XI. Other current liabilities |
0 | 1 | |
| TOTAL EQUITY AND LIABILITIES | 54 247 | 53 554 |
| At 31st December 2017 (in thousands of Euro) |
Notes | 31 December 2017 | 31 December 2016 |
|---|---|---|---|
| I. Revenue |
0 | 70 | |
| A. Dividends |
0 | 70 | |
| B. Other operating revenues |
0 | 0 | |
| II. Other operating expenses |
-161 | -110 | |
| A. Administrative costs |
-161 | -110 | |
| Operating profit | -161 | -40 | |
| III. Profit/Loss from non-current assets |
0 | 11 623 | |
| IV. Financial income |
605 | 657 | |
| V. Financial expenses |
-54 | -1 | |
| Profit before tax | 390 | 12 239 | |
| VI. Income tax expense |
-214 | -45 | |
| Profit for the year | 176 | 12 194 | |
| Other comprehensive income | 31 December 2017 | 31 December 2016 | |
| Net loss/(gain) on available-for-sale financial Assets | 0 | -13 941 | |
| Deferred taxes liabilities on unrealized gain on AFS | 0 | 58 | |
| Net other comprehensive income to be reclassi fied to profit or loss in subsequent periods |
0 | 0 | |
| Total comprehensive income for the year, net of tax | 176 | -1 689 | |
| Profit attributable to equity holders of the parent | 176 | -1 689 | |
| Total comprehensive income attributable to equity holders of the parent |
176 | -1 689 | |
| Earnings per share (profit for the year attributable to common shares): |
|||
| Basic earnings per share | 1.52 | 65.28 | |
| Diluted earnings per share | 1.52 | 65.28 | |
| Earnings per share (profit for the year attributable to founder shares): |
|||
| Basic earnings per share Diluted earnings per share |
10.92 10.92 |
2 214.03 2 214.03 |
| (in thousands of Euro) | Notes | 31 December 2017 | 31 December 2016 |
|---|---|---|---|
| Cash flows from operating activities | 326 | 27 082 | |
| Profit for the year | 176 | 12 194 | |
| Capital Gain on sale of available-for-sales investments | 0 | 0 | |
| Variation of trade and other receivables | 37 | 14 877 | |
| Variation of trade and other payables | 113 | 11 | |
| Cash flows from investing activities | 0 | -7 530 | |
| Purchase of available-for-sale investments | 0 | -10 059 | |
| Sales of available-for-sale investments | 0 | 2 529 | |
| Cash flows from financing activities | 0 | 0 | |
| Dividends paid | 0 | 0 | |
| Purchase of treasury shares | 0 | 0 | |
| Other long-term payables | 0 | 0 | |
| Net increase in cash and cash equivalents | 326 | 19 552 | |
| Cash and cash equivalents as at beginning of year | 23 573 | 3 875 | |
| Cash and cash equivalents as at 31th December | 23 899 | 23 427 |
| ( in ho ds f Eu ) t us an o ro |
Nu be f m r o ha s re s |
S ha re i l ta ca p E U R |
Re lu io t va a n re se rv e E U R |
S ta tu to ry re se rv es E U R |
Av i la b le a re se rv es E U R |
Re in d ta e in ea rn g s E U R |
Pr f i fo t o r he t ea r y E U R |
Tr ea su ry ha s re s E U R |
To l ta E U R |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Ba lan 3 0 Ju 2 0 1 5 t ce a s a ne |
1 0 0 1 0 0 |
2 3 1 4 |
1 7 2 2 5 |
2 3 1 |
5 2 3 |
3 8 7 5 9 |
1 1 5 4 |
7 - 3 1 8 |
5 7 0 1 9 |
|
| O he he ive inc t r c om p re ns om e |
3 2 8 4 - |
- | 3 2 8 4 |
|||||||
| Pr f i fo he t t o r y ea r |
1 6 5 3 |
1 6 5 3 |
||||||||
| To l c he ive inc for he ta t om p re ns om e ea r y |
- | 3 2 8 4 - |
- | - | - | 1 6 5 3 |
- | - | 1 6 3 1 |
|
| D iv i de ds n |
3 - |
- | 3 | |||||||
| Tr fe fro iou t an s r m p rev s y ea r |
1 1 5 4 |
1 1 5 4 - |
- | |||||||
| Tr S ha ea su ry re s |
6 9 - |
- | 6 9 |
|||||||
| Ba lan 3 0 Ju 2 0 1 6 t ce a s a ne |
1 0 0 1 0 0 |
2 3 1 4 |
1 3 9 4 1 |
2 3 1 |
5 2 3 |
3 9 9 1 0 |
1 6 5 3 |
6 - 3 2 5 |
5 5 3 1 6 |
|
| O he he ive inc t r c om p re ns om e |
1 3 9 4 1 - |
- | 1 3 9 4 1 |
|||||||
| Pr f i fo he t t o r y ea r |
1 2 6 1 3 |
1 2 6 1 3 |
||||||||
| To l c he ive inc for he ta t om p re ns om e y ea r |
- | 1 3 9 4 1 - |
- | - | - | 1 2 6 1 3 |
- | - | 1 3 2 8 |
|
| D iv i de ds n |
3 - |
- | 3 | |||||||
| Tr fe fro iou t an s r m p rev s y ea r |
1 6 5 3 |
1 6 5 3 - |
- | |||||||
| Tr S ha ea su ry re s |
6 6 - |
- | 6 6 |
|||||||
| Ba lan 3 0 Ju 2 0 1 t 7 ce a s a ne |
1 0 0 1 0 0 |
2 3 1 4 |
- | 2 3 1 |
5 2 3 |
5 4 1 6 0 |
1 2 6 1 3 |
2 - 3 3 2 |
5 3 9 1 9 |
|
| O he he ive inc t r c om p re ns om e |
- | |||||||||
| Pr f i fo he t t o r y ea r |
1 7 5 |
1 7 5 |
||||||||
| To l c he ive inc for he ta t om p re ns om e y ea r |
- | - | - | - | - | 1 7 5 |
- | 1 7 5 |
||
| D iv i de ds n |
3 - |
- | 3 | |||||||
| Tr fe fro iou t an s r m p rev s y ea r |
1 2 6 1 3 |
1 2 6 1 3 - |
- | |||||||
| Tr S ha ea su ry re s |
- | - | ||||||||
| Ba lan 3 1 De be 2 0 1 7 t ce a s a ce m r |
1 0 0 1 0 0 |
2 3 1 4 |
- | 2 3 1 |
5 2 3 |
5 4 1 7 0 |
5 1 7 |
2 - 3 3 2 |
5 4 0 9 1 |
| (in thousands of Euro) | Available-for sale investments |
|---|---|
| As at 30 June 2016 | 16 528 |
| Fair value adjustment Sales Result of the sales |
449 -14 151 -2 826 |
| As at 30 June 2017 | 0 |
| Acquisitions Fair Value adjustment Sales |
0 0 0 |
| As at 31 December 2017 | 0 |
| (in thousands of euro) | 31 Dec 2017 | 30 June 2017 |
|---|---|---|
| Loans granted Other receivables Interest to be received on loan granted |
30 000 39 309 |
30 000 10 372 |
| Total of Other receivables | 30 348 | 30 382 |
| Other receivables whose recovery is awaited 1 year at the most |
20 348 | 20 382 |
| Other receivables whose recovery is awaited between 1 and 5 years |
10 000 | 10 000 |
Socfinaf has a loan of EUR 20 000 000 and Afico has a loan of EUR 10 000 000.
These 2 loans are receivables on related parties. Also, the loan granted to Afico is a loan issued to a statutory director.
There is due interest on the loan to Socfinaf and Afico for the last quarter.
| Cash and cash equivalents | 23 899 | 23 574 |
|---|---|---|
| Short-term deposits | 2 265 | 2 470 |
| Cash at banks and in hand | 21 634 | 21 104 |
| (in thousands of Euro) | 31 Dec 2017 | 30 June 2017 |
Cash and cash-equivalents consist of cash in hand, bank balances and
short-term deposits in money market instruments.
There are not undrawn borrowing facilities.
There is no restriction to the availability of cash and cash equivalents.
Capital (in units) Common shares Preferred shares Founder shares
| Number of shares as at 30 June 2016 | 100 000 | 100 | 2 400 |
|---|---|---|---|
| Changes during the year | 0 | 0 | 0 |
| Number of shares as at 30 June 2016 | 100 000 | 100 | 2 400 |
| Changes during the year | 0 | 0 | 0 |
| Number of shares as at 31 December 2016 | 100 000 | 100 | 2 400 |
| Number of shares issued, fully paid | 100 000 | 100 | 2 400 |
The subscribed and fully paid capital of EUR 2,314,279 is represented as follows: 100,000: Common shares of a nominal value of Nlg 50 (EUR 22.69) (listed on Euronext Brussels) 100: Preferred stock of a nominal value of Nlg 1,000 (EUR 453.78) (not listed in the stock exchange) 2,400: Founders' shares with no nominal value. (listed on Euronext Brussels)
| Shares outstanding (in units) | Common shares | Preferred shares | Founder shares |
|---|---|---|---|
| Number of shares outstanding as at 30 June 2016 | 94 476 | 100 | 2 182 |
| Changes during the year | -229 | 0 | 0 |
| Number of shares as at 30 June 2017 | 94 247 | 100 | 2 182 |
| Changes during the year | 0 | 0 | 0 |
| Number of shares as at 31 December 2017 | 94 247 | 100 | 2 182 |
At 31 December, the company owned 5.753 (2017: 5.753) of its own common shares, and 218 (2017: 218) of its founders shares.
The extraordinary general meeting as at 10th june 2008 authorised the company to acquire its own shares. The General Meeting as at 19th December 2017 renewed the authorization for 18 months from 10th June 2017. At 31 December, 218 founder's shares and 5.753 ordinary shares have been bought back for a total of 3 322 thousands euros, deducted from the Shareholder's equity.
| Reserves (in thousands of Euro) | Revaluation reserves |
Statutory reserves |
Available reserves |
|---|---|---|---|
| 30 June 2016 | 13 941 | 231 | 523 |
| Changes during the year | -13 941 | 0 | 0 |
| 30 June 2017 | 0 | 231 | 523 |
| Changes during the year | 0 | 0 | 0 |
| 31 December 2017 | 0 | 231 | 523 |
The statutory resrves are relative to article 12,3. a) of the company statutes. These reserves are no more funded as they reached 10% of the capital.
| Distribution of profit (in thousands of euro) | Retained earnings |
Result for the year |
|---|---|---|
| 30 June 2016 | 39 910 | 1 653 |
| Profit of the year | 0 | 12 613 |
| Dividends | -3 | 0 |
| Transfer from previous year | 1 653 | -1 653 |
| 30 June 2017 | 41 560 | 12 613 |
| Profit of the year | 0 | 176 |
| Dividends | -3 | 0 |
| Transfer from previous year | 12 613 | -12 613 |
| 31 December 2017 | 54 170 | 176 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.